Literature DB >> 30720262

Minimalist Design of a Stimuli-Responsive Spherical Nucleic Acid for Conditional Delivery of Oligonucleotide Therapeutics.

Hassan H Fakih1, Johans J Fakhoury1, Danny Bousmail1, Hanadi F Sleiman1.   

Abstract

In this work, we report a component-minimal spherical nucleic acid (SNA) from monodisperse DNA-polymer conjugates that can load and release nucleic acid therapeutics in a stimuli-responsive manner. We show that this vehicle assembles from only four strands, and conditional release of its antisense therapeutic cargo can be induced upon recognition of specific oligonucleotide triggers via strand displacement. The latter (triggers) may be a microRNA that offers additional synergistic therapy, in addition to the previously shown ability of the SNA to load hydrophobic drugs. The SNA is easy to prepare, has dynamic character, releases its cargo only upon the presence of both triggers, and can survive biological conditions while protecting its cargo. The gene silencing potency of the cargo was tested in live cells and shown to be suppressed when loaded in the SNA, and its activity was restored only upon release with the two triggers. This vehicle has the essential characteristics of versatility, ease of synthesis, low cost, highly responsive behavior, and ability to support combination therapies, making it a promising candidate for cell-selective drug delivery and clinical transition.

Entities:  

Keywords:  DNA nanotechnology; antisense oligonucleotides; drug delivery; gene silencing; spherical nucleic acid; stimuli-responsive delivery

Mesh:

Substances:

Year:  2019        PMID: 30720262     DOI: 10.1021/acsami.8b18790

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  6 in total

1.  What's Next after Lipid Nanoparticles? A Perspective on Enablers of Nucleic Acid Therapeutics.

Authors:  Ritam Das; Pintu Kanjilal; Jewel Medeiros; S Thayumanavan
Journal:  Bioconjug Chem       Date:  2022-04-04       Impact factor: 6.069

Review 2.  Functional DNA-Polymer Conjugates.

Authors:  Colette J Whitfield; Meizhou Zhang; Pia Winterwerber; Yuzhou Wu; David Y W Ng; Tanja Weil
Journal:  Chem Rev       Date:  2021-03-19       Impact factor: 60.622

Review 3.  DNA Nanostructures and DNA-Functionalized Nanoparticles for Cancer Theranostics.

Authors:  Fay Nicolson; Akbar Ali; Moritz F Kircher; Suchetan Pal
Journal:  Adv Sci (Weinh)       Date:  2020-10-15       Impact factor: 16.806

4.  Innovative developments and emerging technologies in RNA therapeutics.

Authors:  François Halloy; Annabelle Biscans; Katherine E Bujold; Alexandre Debacker; Alyssa C Hill; Aurélie Lacroix; Olivia Luige; Roger Strömberg; Linda Sundstrom; Jörg Vogel; Alice Ghidini
Journal:  RNA Biol       Date:  2021-12-31       Impact factor: 4.652

5.  Pairing nanoarchitectonics of oligodeoxyribonucleotides with complex diversity: concatemers and self-limited complexes.

Authors:  Anastasia A Zamoskovtseva; Victor M Golyshev; Valeria A Kizilova; Georgiy Yu Shevelev; Dmitrii V Pyshnyi; Alexander A Lomzov
Journal:  RSC Adv       Date:  2022-02-23       Impact factor: 3.361

6.  Spherical nucleic acids: Organized nucleotide aggregates as versatile nanomedicine.

Authors:  Yangmeihui Song; Wenyu Song; Xiaoli Lan; Weibo Cai; Dawei Jiang
Journal:  Aggregate (Hoboken)       Date:  2021-09-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.